This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Ab. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Derek Ogg
Introduction
Derek Ogg is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of modified coagulation agents. His work is characterized by a focus on improving the properties of existing biological compounds.
Latest Patents
Derek Ogg holds a patent for a modified coagulation factor Xa. This invention is directed towards enhancing the capacity of forming crystals compared to its native form. Such crystals are particularly useful for studies involving the active catalytic site of factor Xa when it is complexed with a specific affinity ligand that possesses inhibiting characteristics. He has 1 patent to his name.
Career Highlights
Derek Ogg has built a career at Pharmacia & Upjohn AB, where he has been involved in various innovative projects. His expertise in biochemistry and molecular biology has allowed him to contribute to advancements in medical research and therapeutic applications.
Collaborations
Derek has collaborated with several talented individuals in his field, including Joanna Chmielewska and Tomas Lundqvist. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Derek Ogg's work exemplifies the impact of innovative thinking in the field of biochemistry. His contributions, particularly in the development of modified coagulation agents, highlight the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile